Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient-Reference-Cited by-同舟云学术

Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient

Published:2012 Issue:3 Volume:53 Page:199-201
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Imamura Teruhiko¹,Shiga Taro¹,Kinugawa Koichiro¹,Kato Naoko¹,Endo Miyoko²,Inaba Toshiro¹,Maki Hisataka¹,Hatano Masaru¹,Yao Atsushi¹,Hirata Yasunobu¹,Nagai Ryozo¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

2. Department of Organ Transplantation, The University of Tokyo Hospital

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/53/3/53_199/_pdf

Reference13 articles.

1. 1. Dummer JS, White LT, Ho M, Griffith BP, Hardesty RL, Bahnson HT. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporine. J Infect Dis 1985; 152: 1182-91.

2. 2. Valantine HA. The role of viruses in cardiac allograft vasculopathy. Am J Transplant 2004; 4: 169-77. (Review)

3. 3. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant 2011; 30: 1078-94.

4. 4. Cytomegalovirus. Am J Transplant 2004; 4: 51-8. (Review)

5. 5. Wéclawiak H, Kamar N, Mengelle C, et al. Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients. J Med Virol 2008; 80: 1228-32.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20

2. Evaluation of neutropenia secondary to mycophenolate mofetil associated with valganciclovir in liver transplant patients;FARM HOSP;2021

3. The use of sirolimus in patients with recurrent cytomegalovirus infection after kidney transplantation: A retrospective case series analysis;Saudi Journal of Kidney Diseases and Transplantation;2019

4. Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study;Transplant Infectious Disease;2017-05-09

5. Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients;Transplant Infectious Disease;2016-10-19